Provided By PR Newswire
Last update: Nov 19, 2025
NEW YORK, Nov. 18, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ: AVXL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read more at prnewswire.com3.26
+0.09 (+2.84%)
Find more stocks in the Stock Screener


